#211 | The NUMBER ONE Reason Clinically Proven MedTech Products Still Fail

#211 | The NUMBER ONE Reason Clinically Proven MedTech Products Still Fail

July 9, 2026 · 35 min

About this episode

The episode discusses why clinically proven MedTech products fail commercially despite regulatory approval and positive feedback.

Have you ever wondered why a clinically proven MedTech product can achieve regulatory approval, generate positive feedback, and still fail commercially? Many clinician founders believe that strong clinical evidence is enough to drive adoption. Unfortunately, healthcare doesn't work that way. In this episode, Hakeem speaks with Holly Miller about why adoption is engineered long before launch and how behavioural science, market conditioning, and stakeholder alignment help transform innovative MedTech products from interesting ideas into the new standard of care. Listeners will discover: Why clinical evidence alone rarely changes behaviour or guarantees adoption How to move your MedTech product from a "nice-to-have" to a "must-have" for the right audience The practical adoption strategies that successful MedTech companies use before launching into the market Play this episode now to discover how to engineer adoption before launch and give your MedTech product the best chance of achieving commercial success and becoming the new standard of care. Book a 30min Healthcare Export Accelerator discovery call Message me via DM on Linkedin This podcast is for clinicians and solo founders…

People in this episode

Host: Hakeem Adebiyi

Guest: Holly Miller

Mentioned in this episode

Organizations: MedTech

More episodes of Clinician to CEO : Export Your Medical Device With Confidence By Overcoming Go To Market Roadblocks For Medtech Growth

Explore listener stats, chart rankings, contacts and more on the Clinician to CEO : Export Your Medical Device With Confidence By Overcoming Go To Market Roadblocks For Medtech Growth podcast page.